FLT3 and acute myeloid leukemia: Although much progress has been made in improving treatment outcomes for patients with an acute myeloid leukemia (AML) diagnosis, certain subsets of AML, such as those with a FLT3‐ITD mutation, have poor treatment advances and low survival rates.